Pricing Log in Create free account

ARAVIVE, INC (ARAV) vs Decoy Therapeutics Inc (DCOY)

ARAVIVE, INC and Decoy Therapeutics Inc are both Biotechnology companies. ARAVIVE, INC and Decoy Therapeutics Inc are of similar size ($3.0M and $2.9M). ARAVIVE, INC has negative trailing earnings, so its P/E is not meaningful; Decoy Therapeutics Inc trades at 0.0×. ARAVIVE, INC grew revenue faster over the last twelve months: −19.1% against −60.5%. ARAVIVE, INC has the higher net margin (−569.7% vs −698.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 17 metrics below, Decoy Therapeutics Inc leads on 9 and ARAVIVE, INC on 8.

Valuation

Metric ARAV DCOY Biotechnology median
P/E n/m 0.01 8.50
P/S 0.43 0.30 9.71
P/B 1.78 0.14 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.05 0.49 0.64
EV/Sales (0.44) (3.48) 9.21
Earnings yield (1,500.00%) 15,691.12% (33.15%)
Free cash flow yield (2,072.58%) (1,677.54%) (25.50%)

Profitability

Metric ARAV DCOY Biotechnology median
Gross margin 100.00% 10.57% 65.16%
Operating margin (847.42%) (706.88%) 0.00%
Net margin (569.65%) (698.79%) 0.00%
Free cash flow margin (849.92%) (432.43%) 0.00%
Return on equity (475.98%) (827.77%) (56.36%)
Return on assets (144.19%) (278.04%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ARAV DCOY Biotechnology median
Revenue growth (TTM) (19.11%) (60.49%) 6.02%
EPS growth (last fiscal year) (7.69%) (85.66%) 30.26%
Revenue growth, 5-year CAGR (25.57%) 12.73% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARAV DCOY Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.98 1.83 4.72
Net debt to EBITDA 0.77 0.85 0.96

Dividend

Metric ARAV DCOY Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ARAV DCOY Biotechnology median
Market cap 2.95m 2.93m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack